Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions.
$0.85+4.27%
报价 2026-11-06
市值
$86.1M
EV
–
PE (TTM)
–
预期 PE
–
52 周区间距高点 -85.6%
$0.81$5.89
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Medical - Instruments & Supplies| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| NYXHNyxoah S.A. | $86.1M | +4.3% | – | 51.3% | – | – | – | |
| PDEXPro-Dex, Inc. | $202.1M | +3.2% | 0.0% | 31.4% | 17.4x | 17.0x | 34.0x | |
| NNNNAnbio Biotechnology Class A Ordinary Shares | $170.7M | +8.4% | – | 86.1% | 19.7x | 24.6x | – | |
| KRMDKORU Medical Systems, Inc. | $141.9M | +2.0% | +18.8% | 60.3% | – | – | – | |
| STXSStereotaxis, Inc. | $109.2M | +3.8% | +20.1% | 55.6% | – | – | – | |
| MBOTMicrobot Medical Inc. | $74.6M | +3.7% | +4900.0% | -9.5% | – | – | – | |
| POCIPrecision Optics Corporation, Inc. | $53.6M | -1.3% | – | 9.7% | – | – | – | |
| DXRDaxor Corporation | $49.3M | -2.1% | +7856.1% | -57.5% | 5.8x | 5.6x | 292.1x | |
| HBIOHarvard Bioscience, Inc. | $38.1M | -1.2% | +3.1% | 53% | – | 11.2x | 7.4x | |
| 同行中位数 | – | – | +19.5% | 42.2% | 17.4x | 14.1x | 34.0x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
报告货币 EUR（非美元）暂无季度数据（首次研究运行后填充）。
研究材料
电话会纪要摘要
暂无纪要摘要。